DMH News

Central Illinois Cancer Research Program Receives Grant From The National Cancer Institute


Setpember 29,2010 DECATUR, IL — The National Cancer Institute has awarded the Central Illinois Community Clinical Oncology Program (CICCOP) $1,270,000 to help fund cancer research initiatives in the local community this year. Decatur Memorial Hospital serves as the central office for the CICCOP.

The funds received from the National Cancer Institute (NCI) will be used to support cancer research in Decatur (Decatur Memorial Hospital, Cancer Care Specialists, S.C.), Effingham (Crossroads Cancer Center), Elgin (Sherman Hospital), and Springfield (Memorial Medical Center, Central Illinois Hematology Oncology Clinic, and SIU Medical Center). This research grant marks the 25th year of funding from the National Cancer Institute.

“The Central Illinois CCOP continues to be the leader in providing cutting edge cancer treatments for the citizens of Central Illinois. This continued funding, based on an outstanding competitive NCI review, underscores that CICCOP performs world class research right here at home,” said Karen Cheek, Director of Cancer Research at Decatur Memorial Hospital.

Last year, physician researchers at Central Illinois CCOP facilities enrolled 375 patients on cancer treatment and cancer symptom management trials. These trials would not have been possible without funding from the National Cancer Institute. “Without this grant award, new drugs and treatment options would not be available, and patients would have to go to cancer centers hundreds of miles away from home to get these novel treatments, Cheek said.”

Over the past 25 years, the Central Illinois Community Clinical Oncology Program has enrolled approximately 7,550 patients on National Cancer Institute trials. Approximately 4,500 patients were enrolled in Decatur.

The Community Clinical Oncology Program was established in 1983 to develop and conduct state-of-the-art cancer prevention, control and treatment clinical trials with significant involvement of community oncologists and populations they serve.